Unresectable Stage III Non-Small Cell Lung Cancer: Could Durvalumab Be Safe and Effective in Real-Life Clinical Scenarios? Results of a Single-Center Experience
FRONTIERS IN ONCOLOGY(2023)
关键词
non-small cell lung cancer (NSCLC),stage III,durvalumab,chemo-radiotherapy (CRT),real-world data (RWD)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要